Our previous deconvolution of bulk liver RNA-Seq data from a large cohort of patients with MASLD (GSE213623) indicated that hepatocyte Smo expression inversely correlates with MASLD severity in people (16). This evidence concerns the gene SMO and metabolic dysfunction-associated steatotic liver disease.